Anti-SLIK5/ SLITRK5/ LRRC11 monoclonal antibody

Anti-SLIK5/ SLITRK5/ LRRC11 antibody for FACS & in-vivo assay

Target products collectionGo to SLITRK5/SLITRK5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1687-Ab-1/ GM-Tg-hg-MP1687-Ab-2Anti-Human SLITRK5 monoclonal antibodyHuman
GM-Tg-rg-MP1687-Ab-1/ GM-Tg-rg-MP1687-Ab-2Anti-Rat SLITRK5 monoclonal antibodyRat
GM-Tg-mg-MP1687-Ab-1/ GM-Tg-mg-MP1687-Ab-2Anti-Mouse SLITRK5 monoclonal antibodyMouse
GM-Tg-cynog-MP1687-Ab-1/ GM-Tg-cynog-MP1687-Ab-2Anti-Cynomolgus/ Rhesus macaque SLITRK5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1687-Ab-1/ GM-Tg-felg-MP1687-Ab-2Anti-Feline SLITRK5 monoclonal antibodyFeline
GM-Tg-cang-MP1687-Ab-1/ GM-Tg-cang-MP1687-Ab-2Anti-Canine SLITRK5 monoclonal antibodyCanine
GM-Tg-bovg-MP1687-Ab-1/ GM-Tg-bovg-MP1687-Ab-2Anti-Bovine SLITRK5 monoclonal antibodyBovine
GM-Tg-equg-MP1687-Ab-1/ GM-Tg-equg-MP1687-Ab-2Anti-Equine SLITRK5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1687-Ab-1/ GM-Tg-hg-MP1687-Ab-2; GM-Tg-rg-MP1687-Ab-1/ GM-Tg-rg-MP1687-Ab-2;
GM-Tg-mg-MP1687-Ab-1/ GM-Tg-mg-MP1687-Ab-2; GM-Tg-cynog-MP1687-Ab-1/ GM-Tg-cynog-MP1687-Ab-2;
GM-Tg-felg-MP1687-Ab-1/ GM-Tg-felg-MP1687-Ab-2; GM-Tg-cang-MP1687-Ab-1/ GM-Tg-cang-MP1687-Ab-2;
GM-Tg-bovg-MP1687-Ab-1/ GM-Tg-bovg-MP1687-Ab-2; GM-Tg-equg-MP1687-Ab-1/ GM-Tg-equg-MP1687-Ab-2
Products NameAnti-SLITRK5 monoclonal antibody
Formatmab
Target NameSLITRK5
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLITRK5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SLIK5/ SLITRK5/ LRRC11 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm004768mouse Slitrk5 Lentivirus plasmid
    ORF Viral VectorvGMLPm004768mouse Slitrk5 Lentivirus particle


    Target information

    Target IDGM-MP1687
    Target NameSLITRK5
    Gene ID26050,75409,306152,705032,485513,101093488,781586,100050289
    Gene Symbol and Synonyms2610019D03Rik,bA364G4.2,LRRC11,SLITRK5
    Uniprot AccessionO94991
    Uniprot Entry NameSLIK5_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000165300
    Target ClassificationN/A

    The target: SLITRK5, gene name: SLITRK5, also named as LRRC11, bA364G4.2. Members of the SLITRK family, such as SLITRK5, are integral membrane proteins with 2 N-terminal leucine-rich repeat (LRR) domains similar to those of SLIT proteins (see SLIT1; MIM 603742). Most SLITRKs, including SLITRK5, also have C-terminal regions that share homology with neurotrophin receptors (see NTRK1; MIM 191315). SLITRKs are expressed predominantly in neural tissues and have neurite-modulating activity (Aruga et al., 2003 [PubMed 14557068]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.